Literature DB >> 23035215

Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2.

Benjamin R Trible1, Andrew W Suddith, Maureen A Kerrigan, Ada G Cino-Ozuna, Richard A Hesse, Raymond R R Rowland.   

Abstract

Porcine circovirus type 2 (PCV2) capsid protein (CP) is the only protein necessary for the formation of the virion capsid, and recombinant CP spontaneously forms virus-like particles (VLPs). Located within a single CP subunit is an immunodominant epitope consisting of residues 169 to 180 [CP(169-180)], which is exposed on the surface of the subunit, but, in the structural context of the VLP, the epitope is buried and inaccessible to antibody. High levels of anti-CP(169-180) activity are associated with porcine circovirus-associated disease (PCVAD). The purpose of this study was to investigate the role of the immune response to monomer CP in the development of PCVAD. The approach was to immunize pigs with CP monomer, followed by challenge with PCV2 and porcine reproductive and respiratory syndrome virus (PRRSV). To maintain the CP immunogen as a stable monomer, CP(43-233) was fused to ubiquitin (Ub-CP). Size exclusion chromatography showed that Ub-CP was present as a single 33-kDa protein. Pigs immunized with Ub-CP developed a strong antibody response to PCV2, including antibodies against CP(169-180). However, only low levels of virus neutralizing activity were detected, and viremia levels were similar to those of nonimmunized pigs. As a positive control, immunization with baculovirus-expressed CP (Bac-CP) resulted in high levels of virus neutralizing activity, small amounts of anti-CP(169-180) activity, and the absence of viremia in pigs following virus challenge. The data support the role of CP(169-180) as an immunological decoy and illustrate the importance of the structural form of the CP immunogen in determining the outcome following infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035215      PMCID: PMC3503079          DOI: 10.1128/JVI.01763-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  An efficient system for high-level expression and easy purification of authentic recombinant proteins.

Authors:  Ann-Maree Catanzariti; Tatiana A Soboleva; David A Jans; Philip G Board; Rohan T Baker
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

2.  The effects of immuno-modulation on the clinical and pathological expression of postweaning multisystemic wasting syndrome.

Authors:  S C Kyriakis; K Saoulidis; S Lekkas; Ch C Miliotis; P A Papoutsis; S Kennedy
Journal:  J Comp Pathol       Date:  2002-01       Impact factor: 1.311

3.  PCV-2 genotype definition and nomenclature.

Authors:  J Segalés; A Olvera; L Grau-Roma; C Charreyre; H Nauwynck; L Larsen; K Dupont; K McCullough; J Ellis; S Krakowka; A Mankertz; M Fredholm; C Fossum; S Timmusk; N Stockhofe-Zurwieden; V Beattie; D Armstrong; B Grassland; P Baekbo; G Allan
Journal:  Vet Rec       Date:  2008-06-28       Impact factor: 2.695

4.  Experimental inoculation of conventional pigs with porcine reproductive and respiratory syndrome virus and porcine circovirus 2.

Authors:  A Rovira; M Balasch; J Segalés; L García; J Plana-Durán; C Rosell; H Ellerbrok; A Mankertz; M Domingo
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes.

Authors:  D Mahé; P Blanchard; C Truong; C Arnauld; P Le Cann; R Cariolet; F Madec; E Albina; A Jestin
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

6.  Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication.

Authors:  G M Allan; F McNeilly; J Ellis; S Krakowka; B Meehan; I McNair; I Walker; S Kennedy
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

7.  Porcine circovirus type 2 (PCV-2) coinfections in US field cases of postweaning multisystemic wasting syndrome (PMWS).

Authors:  F J Pallarés; P G Halbur; T Opriessnig; S D Sorden; D Villar; B H Janke; M J Yaeger; D J Larson; K J Schwartz; K J Yoon; L J Hoffman
Journal:  J Vet Diagn Invest       Date:  2002-11       Impact factor: 1.279

8.  Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.

Authors:  M Ostrowski; J A Galeota; A M Jar; K B Platt; F A Osorio; O J Lopez
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Replication of porcine circovirus type 1 requires two proteins encoded by the viral rep gene.

Authors:  A Mankertz; B Hillenbrand
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

10.  Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus.

Authors:  T Opriessnig; S Yu; J M Gallup; R B Evans; M Fenaux; F Pallares; E L Thacker; C W Brockus; M R Ackermann; P Thomas; X J Meng; P G Halbur
Journal:  Vet Pathol       Date:  2003-09       Impact factor: 2.221

View more
  15 in total

1.  PCV2 Induces Reactive Oxygen Species To Promote Nucleocytoplasmic Translocation of the Viral DNA Binding Protein HMGB1 To Enhance Its Replication.

Authors:  Renjie Sun; Siqi Sun; Yikai Zhang; Yingshan Zhou; Ying Shan; Xiaoliang Li; Weihuan Fang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.

Authors:  Yang Zhan; Wanting Yu; Xiong Cai; Xinnuo Lei; Hongyu Lei; Aibing Wang; Yujie Sun; Naidong Wang; Zhibang Deng; Yi Yang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  Circovirus transport proceeds via direct interaction of the cytoplasmic dynein IC1 subunit with the viral capsid protein.

Authors:  Jingjing Cao; Cui Lin; Huijuan Wang; Lun Wang; Niu Zhou; Yulan Jin; Min Liao; Jiyong Zhou
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

4.  Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.

Authors:  Megan C Niederwerder; Bhupinder Bawa; Nick V L Serão; Benjamin R Trible; Maureen A Kerrigan; Joan K Lunney; Jack C M Dekkers; Raymond R R Rowland
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

5.  An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus.

Authors:  Randall S Prather; Raymond R R Rowland; Catherine Ewen; Benjamin Trible; Maureen Kerrigan; Bhupinder Bawa; Jennifer M Teson; Jiude Mao; Kiho Lee; Melissa S Samuel; Kristin M Whitworth; Clifton N Murphy; Tina Egen; Jonathan A Green
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

Review 6.  Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.

Authors:  Anbu K Karuppannan; Tanja Opriessnig
Journal:  Viruses       Date:  2017-05-06       Impact factor: 5.048

7.  Phylogeographic and genetic characterization of porcine circovirus type 2 in Taiwan from 2001-2017.

Authors:  Guang-Ting Tsai; Yung-Cheng Lin; Wei-Hao Lin; Jih-Hui Lin; Ming-Tang Chiou; Hsin-Fu Liu; Chao-Nan Lin
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

8.  Immunogenicity of plant-produced porcine circovirus-like particles in mice.

Authors:  Cornelius J Gunter; Guy L Regnard; Edward P Rybicki; Inga I Hitzeroth
Journal:  Plant Biotechnol J       Date:  2019-03-10       Impact factor: 9.803

9.  Porcine Circovirus 2 Manipulates the PERK-ERO1α Axis of the Endoplasmic Reticulum To Favor Its Replication by Derepressing Viral DNA from HMGB1 Sequestration within Nuclei.

Authors:  Renjie Sun; Zhuofan Deng; Xiao Han; Yikai Zhang; Yingshan Zhou; Ying Shan; Weihuan Fang; Xiaoliang Li
Journal:  J Virol       Date:  2021-07-21       Impact factor: 5.103

10.  Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2.

Authors:  Peiyang Ding; Teng Zhang; Yafei Li; Man Teng; Yaning Sun; Xiao Liu; Shujun Chai; Enmin Zhou; Qianyue Jin; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2017-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.